COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.
Candidemia in COVID‐19 treated with corticosteroids and tocilizumab